| Study title |
Genentech: PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BFKB8488A COMPARED WITH PLACEBO IN PATIENTS WITH NASH |
| Disease or condition |
NAFLD/NASH with Fibrosis |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
BFKB8488A or Placebo |
| Phase |
2 |
| Study site |
Duke University |
| Study location |
Durham, NC |
| Principal investigator |
Manal Abdelmalek, MD; manal.abdelmalek@duke.edu |
| Study coordinator |
Lauren Roberson; lauren.roberson@duke.edu |
| Phone contact |
(919) 681-9591 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT04171765 |
